SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-20-012194
Filing Date
2020-11-12
Accepted
2020-11-12 09:19:52
Documents
41
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT mnpr_10q09302020.htm 10-Q 629085
2 MATERIAL CONTRACTS exhibit10-1.htm EX-10 96481
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31-1.htm EX-31 11587
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31-2.htm EX-31 11539
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit32-1.htm EX-32 8915
  Complete submission text file 0001654954-20-012194.txt   2269349

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mono-20200930.xml EX-101.INS 305356
7 XBRL TAXONOMY EXTENSION SCHEMA mono-20200930.xsd EX-101.SCH 16045
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mono-20200930_cal.xml EX-101.CAL 25946
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mono-20200930_def.xml EX-101.DEF 53017
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mono-20200930_lab.xml EX-101.LAB 150262
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mono-20200930_pre.xml EX-101.PRE 118844
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 201303907
SIC: 2834 Pharmaceutical Preparations